Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population.

Petrovics G, Price DK, Lou H, Chen Y, Garland L, Bass S, Jones K, Kohaar I, Ali A, Ravindranath L, Young D, Cullen J, Dorsey TH, Sesterhenn IA, Brassell SA, Rosner IL, Ross D, Dahut W, Ambs S, Figg WD, Srivastava S, Dean M.

Prostate Cancer Prostatic Dis. 2018 Dec 12. doi: 10.1038/s41391-018-0114-1. [Epub ahead of print]

PMID:
30542053
2.

Strategies not accompanied by a mental health professional to address anxiety and depression in children and young people: a scoping review of range and a systematic review of effectiveness.

Wolpert M, Dalzell K, Ullman R, Garland L, Cortina M, Hayes D, Patalay P, Law D.

Lancet Psychiatry. 2019 Jan;6(1):46-60. doi: 10.1016/S2215-0366(18)30465-6. Epub 2018 Dec 3. Review.

PMID:
30522980
3.

A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico.

Diaz-Zabala HJ, Ortiz AP, Garland L, Jones K, Perez CM, Mora E, Arroyo N, Oleksyk TK, Echenique M, Matta JL, Dean M, Dutil J.

Cancers (Basel). 2018 Nov 2;10(11). pii: E419. doi: 10.3390/cancers10110419.

4.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?

Kim S, Bull DA, Garland L, Khalpey Z, Stea B, Yi S, Hsu CC.

Ann Thorac Surg. 2019 Jan;107(1):194-201. doi: 10.1016/j.athoracsur.2018.07.081. Epub 2018 Sep 29.

PMID:
30278171
5.

Regional Changes in Brain 18F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes.

Eshghi N, Garland LL, Choudhary G, Hsu CC, Eshghi A, Han J, Hamilton RJ, Krupinski E, Kuo PH.

J Nucl Med Technol. 2018 Dec;46(4):355-358. doi: 10.2967/jnmt.118.212316. Epub 2018 Aug 3.

PMID:
30076247
6.

Quantifying fear effects on prey demography in nature.

Peers MJL, Majchrzak YN, Neilson E, Lamb CT, Hämäläinen A, Haines JA, Garland L, Doran-Myers D, Broadley K, Boonstra R, Boutin S.

Ecology. 2018 Aug;99(8):1716-1723. doi: 10.1002/ecy.2381. Epub 2018 Jun 21.

PMID:
29897623
7.

Characterization of carfilzomib-resistant non-small cell lung cancer cell lines.

Hanke NT, Imler E, Marron MT, Seligmann BE, Garland LL, Baker AF.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1317-1327. doi: 10.1007/s00432-018-2662-0. Epub 2018 May 15.

PMID:
29766327
8.

Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.

Lou H, Gharzouzi E, Guerra SP, Domgue JF, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, Morales H, Argueta V, Rosingh A, van Aerde-van Nunen FJHB, Lopez G, Pinedo HM, Schiffman M, Dean M, Orozco R.

BMC Cancer. 2018 May 15;18(1):562. doi: 10.1186/s12885-018-4438-y.

9.

18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer.

Eshghi N, Garland LL, Nia E, Betancourt R, Krupinski E, Kuo PH.

J Nucl Med Technol. 2018 Sep;46(3):260-264. doi: 10.2967/jnmt.117.204933. Epub 2018 Mar 29.

PMID:
29599403
10.

Double-negative (CD27-IgD-) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations.

Centuori SM, Gomes CJ, Kim SS, Putnam CW, Larsen BT, Garland LL, Mount DW, Martinez JD.

J Transl Med. 2018 Feb 15;16(1):30. doi: 10.1186/s12967-018-1404-z.

11.

Diffusion Tensor Imaging of the Ankle as a Possible Predictor of Chemotherapy Induced Peripheral Neuropathy: Pilot Study.

Gimber LH, Garland L, Krupinski EA, Chadaz TS, Schwenk M, Najafi B, Taljanovic MS.

Curr Probl Diagn Radiol. 2019 Mar - Apr;48(2):121-126. doi: 10.1067/j.cpradiol.2017.12.012. Epub 2018 Jan 6.

PMID:
29397266
12.

Incidence of Brain Metastases on Follow-up 18F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain?

Nia ES, Garland LL, Eshghi N, Nia BB, Avery RJ, Kuo PH.

J Nucl Med Technol. 2017 Sep;45(3):193-197. doi: 10.2967/jnmt.117.194571. Epub 2017 Jul 13.

13.

Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.

Yang XR, Devi BCR, Sung H, Guida J, Mucaki EJ, Xiao Y, Best A, Garland L, Xie Y, Hu N, Rodriguez-Herrera M, Wang C, Jones K, Luo W, Hicks B, Tang TS, Moitra K, Rogan PK, Dean M.

Breast Cancer Res Treat. 2017 Oct;165(3):687-697. doi: 10.1007/s10549-017-4356-8. Epub 2017 Jun 29.

PMID:
28664506
14.

Salicylic acid treatment and expression of an RNA-dependent RNA polymerase 1 transgene inhibit lethal symptoms and meristem invasion during tobacco mosaic virus infection in Nicotiana benthamiana.

Lee WS, Fu SF, Li Z, Murphy AM, Dobson EA, Garland L, Chaluvadi SR, Lewsey MG, Nelson RS, Carr JP.

BMC Plant Biol. 2016 Jan 13;16:15. doi: 10.1186/s12870-016-0705-8.

15.

Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.

Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B.

Gerontology. 2016;62(5):553-63. doi: 10.1159/000442253. Epub 2015 Dec 18.

PMID:
26678611
16.

Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.

Dean M, Boland J, Yeager M, Im KM, Garland L, Rodriguez-Herrera M, Perez M, Mitchell J, Roberson D, Jones K, Lee HJ, Eggebeen R, Sawitzke J, Bass S, Zhang X, Robles V, Hollis C, Barajas C, Rath E, Arentz C, Figueroa JA, Nguyen DD, Nahleh Z.

Gigascience. 2015 Nov 4;4:50. doi: 10.1186/s13742-015-0088-z. eCollection 2015.

17.

Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.

Hanke NT, Garland LL, Baker AF.

J Cancer Res Clin Oncol. 2016 Mar;142(3):549-60. doi: 10.1007/s00432-015-2047-6. Epub 2015 Sep 18.

18.

Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway.

Lou H, Villagran G, Boland JF, Im KM, Polo S, Zhou W, Odey U, Juárez-Torres E, Medina-Martínez I, Roman-Basaure E, Mitchell J, Roberson D, Sawitzke J, Garland L, Rodríguez-Herrera M, Wells D, Troyer J, Pinto FC, Bass S, Zhang X, Castillo M, Gold B, Morales H, Yeager M, Berumen J, Alvirez E, Gharzouzi E, Dean M.

Clin Cancer Res. 2015 Dec 1;21(23):5360-70. doi: 10.1158/1078-0432.CCR-14-1837. Epub 2015 Jun 16.

19.

Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.

Baker AF, Hanke NT, Sands BJ, Carbajal L, Anderl JL, Garland LL.

J Exp Clin Cancer Res. 2014 Dec 31;33:111. doi: 10.1186/s13046-014-0111-8.

20.

SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).

Ou SH, Moon J, Garland LL, Mack PC, Testa JR, Tsao AS, Wozniak AJ, Gandara DR.

J Thorac Oncol. 2015 Feb;10(2):387-91. doi: 10.1097/JTO.0000000000000360.

21.

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.

Chow HH, Garland LL, Heckman-Stoddard BM, Hsu CH, Butler VD, Cordova CA, Chew WM, Cornelison TL.

J Transl Med. 2014 Aug 14;12:223. doi: 10.1186/s12967-014-0223-0.

22.

Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma.

Mount DW, Putnam CW, Centouri SM, Manziello AM, Pandey R, Garland LL, Martinez JD.

BMC Med Genomics. 2014 Jun 10;7:33. doi: 10.1186/1755-8794-7-33.

23.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B.

J Clin Oncol. 2013 Mar 1;31(7):895-902. doi: 10.1200/JCO.2011.40.1174. Epub 2013 Jan 22.

24.

Improving documentation of treatment escalation decisions in acute care.

Dahill M, Powter L, Garland L, Mallett M, Nolan J.

BMJ Qual Improv Rep. 2013 Aug 21;2(1). pii: u200617.w1077. doi: 10.1136/bmjquality.u200617.w1077. eCollection 2013.

25.

Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers.

Hakim IA, Harris R, Garland L, Cordova CA, Mikhael DM, Sherry Chow HH.

Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2193-200. doi: 10.1158/1055-9965.EPI-12-0820. Epub 2012 Oct 2.

26.

Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509.

Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman M, Gandara DR.

J Thorac Oncol. 2011 Nov;6(11):1938-45. doi: 10.1097/JTO.0b013e318229586e.

27.

Chemotherapy for malignant pleural mesothelioma.

Garland LL.

Curr Treat Options Oncol. 2011 Jun;12(2):181-8. doi: 10.1007/s11864-011-0152-6.

PMID:
21468683
28.

A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria.

Tsao AS, Garland L, Redman M, Kernstine K, Gandara D, Marom EM.

J Thorac Oncol. 2011 Mar;6(3):598-601. doi: 10.1097/JTO.0b013e318208c83d.

29.

Individualizing mesothelioma treatment: small steps into a brighter future.

Garland L, Flores R, Tsao A.

Clin Lung Cancer. 2010 Nov 1;11(6):371-3. doi: 10.3816/CLC.2010.n.048. No abstract available.

PMID:
21062727
30.

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA, Alberts DS.

Cancer Prev Res (Phila). 2010 Sep;3(9):1168-75. doi: 10.1158/1940-6207.CAPR-09-0155. Epub 2010 Aug 17.

31.

Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.

Gualberto A, Dolled-Filhart M, Gustavson M, Christiansen J, Wang YF, Hixon ML, Reynolds J, McDonald S, Ang A, Rimm DL, Langer CJ, Blakely J, Garland L, Paz-Ares LG, Karp DD, Lee AV.

Clin Cancer Res. 2010 Sep 15;16(18):4654-65. doi: 10.1158/1078-0432.CCR-10-0089. Epub 2010 Jul 29. Retraction in: Clin Cancer Res. 2014 Jun 15;20(12):3358.

32.

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin.

Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A.

J Thorac Oncol. 2009 Nov;4(11):1397-403. doi: 10.1097/JTO.0b013e3181ba2f1d.

33.

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, Blakely LJ, Eisenberg PD, Langer CJ, Blumenschein G Jr, Johnson FM, Green S, Gualberto A.

J Clin Oncol. 2009 May 20;27(15):2516-22. doi: 10.1200/JCO.2008.19.9331. Epub 2009 Apr 20. Retraction in: J Clin Oncol. 2012 Nov 20;30(33):4179.

PMID:
19380445
34.

Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.

Nguyen NP, Garland L, Welsh J, Hamilton R, Cohen D, Vinh-Hung V.

Cancer Treat Rev. 2008 Dec;34(8):719-27. doi: 10.1016/j.ctrv.2008.06.001. Epub 2008 Jul 26. Review.

PMID:
18657910
35.

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.

Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE.

Clin Cancer Res. 2007 Oct 15;13(20):6175-81.

36.

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.

Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJ, Testa JR, Altomare DA, Borden EC.

J Clin Oncol. 2007 Jun 10;25(17):2406-13.

PMID:
17557954
37.
38.

Family nursing and the management of pain in children.

Garland L, Kenny G.

Paediatr Nurs. 2006 Jul;18(6):18-20. Review.

PMID:
16881497
39.

A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors.

Garland LL, Hidalgo M, Mendelson DS, Ryan DP, Arun BK, Lovalvo JL, Eiseman IA, Olson SC, Lenehan PF, Eder JP.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4274-82.

40.

The absolute bioavailability of oral vinorelbine in patients with solid tumors.

Lush RM, McCune JS, Tetteh L, Thompson JA, Mahany JJ, Garland L, Suttle AB, Sullivan DM.

Cancer Chemother Pharmacol. 2005 Dec;56(6):578-84. Epub 2005 Jul 7.

PMID:
16001165
41.

Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor.

Garland L, Gitlitz B, Ebbinghaus S, Pan H, de Haan H, Puri RK, Von Hoff D, Figlin R.

J Immunother. 2005 Jul-Aug;28(4):376-81.

PMID:
16000956
42.

Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy.

Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, Grendys E.

J Pain Symptom Manage. 2004 Jul;28(1):7-18.

PMID:
15223080
43.
44.

Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.

Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91.

45.

Risk adjusted mortality of critical illness in a defined geographical region.

Henderson AJ, Garland L, Warne S, Bailey L, Weir P, Edees S.

Arch Dis Child. 2002 Mar;86(3):194-9.

46.

Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.

Garland L, Robinson LA, Wagner H.

Chest Surg Clin N Am. 2001 Feb;11(1):69-100, viii. Review.

PMID:
11253602
47.

Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation.

Kirsner RS, Spencer J, Falanga V, Garland LE, Kerdel FA.

Dermatol Surg. 1996 Dec;22(12):1015-8.

PMID:
9078313
48.

DES-ja vu.

Schapira D, Garland L.

Oncol Rep. 1996 Jan;3(1):209-12.

PMID:
21594346
49.

The National Cancer Institute Silicone Implant/Multiple Myeloma Registry.

Rabkin CS, Silverman S, Tricot G, Garland LL, Ballester O, Potter M.

Curr Top Microbiol Immunol. 1996;210:385-7. No abstract available.

PMID:
8565581
50.

Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk.

Garland LL, Ballester OF, Vasey FB, Benson K, Moscinski LC, Farmelo MJ, Rodriguez MJ, Rapaport DP.

Curr Top Microbiol Immunol. 1996;210:361-6. No abstract available.

PMID:
8565578

Supplemental Content

Loading ...
Support Center